W. Ma
W. Ma publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments and Acute Myeloid Leukemia Research.
- World rank
- #6,651,903 of 7,710,434 ranked researchers
- Rank in United States
- #1,542,039 of 1,627,098
- Works
- 20
- Citations
- 97
- Citations per work
- 4.9
What does W. Ma research?
W. Ma's work is mostly in Medicine (68%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1468.5%
- Medicine1468.5%
- Everything else317.5%
- Life Sciences314.0%
- 1Hematology28% of their works
- 2Genetics23% of their works
- 3Molecular Biology14% of their works
- 4Rheumatology7% of their works
- 5Radiology, Nuclear Medicine and Imaging5% of their works
- 6Pathology and Forensic Medicine5% of their works
Research topics
- Chronic Lymphocytic Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Monoclonal and Polyclonal Antibodies Research
- Eosinophilic Disorders and Syndromes
- Cancer Genomics and Diagnostics
Which keywords describe W. Ma's research?
The keywords of their largest research topics: Prognostic Factors, Rituximab, BCR-ABL, Chronic Lymphocytic Leukemia, Genomic Aberrations, Imatinib, Classification and Acute Myeloid Leukemia.
- Cancer Genomics
- Myelofibrosis
- Lymphoma
- Hypereosinophilic Syndrome
- Fc Receptors
- AML
- Imatinib
- Chronic Lymphocytic Leukemia
- Rituximab
- Prognostic Factors
- BCR-ABL
- Genomic Aberrations
- Classification
- Acute Myeloid Leukemia
- Fusion Genes
- JAK2 Mutation
- Molecular Profiling
- Therapeutic Antibodies
- Mutational Signatures
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Prognostic Factors132 topics
- Rituximab122 topics
- BCR-ABL91 topic
- Chronic Lymphocytic Leukemia91 topic
- Genomic Aberrations91 topic
- Imatinib91 topic
- Classification62 topics
- AML41 topic
- Acute Myeloid Leukemia41 topic
- Fc Receptors31 topic
- Fusion Genes31 topic
- Hypereosinophilic Syndrome31 topic
- JAK2 Mutation31 topic
- Lymphoma31 topic
- Molecular Profiling31 topic
- Myelofibrosis31 topic
- Therapeutic Antibodies31 topic
- Cancer Genomics21 topic
- Mutational Signatures21 topic
Where does W. Ma work?
W. Ma's main affiliation in the publication record is Quest Diagnostics (United States), United States.
How many publications and citations does W. Ma have?
OpenAlex counts 20 works and 97 citations for W. Ma, an h-index of 7, ranking #6,651,903 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named W. Ma
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about W. Ma. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.